Molecular and cellular mechanisms of cardiac fibrosis in Friedreich ataxia
Evaluating the cardioprotective effect of omaveloxolone on Friedreich ataxia heart disease
Role of the Thromboxane-Prostanoid Receptor in FRDA Cardiomyopathy
Advancing novel mitochondrial therapies for FA cardiomyopathy: a pragmatic collaboration to move new therapies forward
Cardiac Imaging Biomarkers in Friedreich’s Ataxia